-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$76.0040.48% Upside
Soleno Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. has been rated by research analysts at Stifel Nicolaus, Oppenheimer, Piper Sandler, Robert W. Baird in the past 90 days.